Publication | Closed Access

Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma

Cancer ResearchMedicineCancer Cell BiologyJak/stat PathwayTherapeutic StrategyLiver CancerSp/cd44+ Tumorigenic CellsRadiation OncologyCancer BiologyCell BiologyCell SignalingHepatocellular CarcinomaTumor BiologyJak-stat Signaling Pathway